Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study

被引:3
|
作者
Makita, Kenji [1 ,2 ,3 ,5 ]
Hamamoto, Yasushi [1 ]
Kanzaki, Hiromitsu [1 ]
Nagasaki, Kei [1 ]
Kozuki, Toshiyuki [4 ]
机构
[1] Natl Hosp Org, Dept Radiat Oncol, Shikoku Canc Ctr, Matsuyama, Ehime 7910280, Japan
[2] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910295, Japan
[3] Ehime Prefectural Cent Hosp, Dept Radiol, Matsuyama, Ehime 7900024, Japan
[4] Natl Hosp Org, Dept Thorac Oncol & Med, Shikoku Canc Ctr, Matsuyama, Ehime 7910280, Japan
[5] Natl Hosp Org, Shikoku Canc Ctr, Dept Radiat Oncol, Kou 160 Minami Umenomoto Machi, Matsuyama, Ehime 7910280, Japan
关键词
bone metastasis; lung cancer; palliative; radiotherapy; local control; TO-LYMPHOCYTE RATIO; RADIATION-THERAPY; SKELETAL METASTASES; ZOLEDRONIC ACID; CHEMOTHERAPY; INFLAMMATION; DENOSUMAB; SURVIVAL;
D O I
10.3892/ol.2023.13889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone metastasis is common in advanced lung cancer, with the incidence reported to be 30%, and radiotherapy (RT) is used for pain relief from bone metastasis. The present study aimed to identify factors affecting local control (LC) of bone metastasis from lung cancer and to assess the significance of moderate RT dose escalation. This was a retrospective cohort study, where LC of bone metastasis from lung cancer that had received palliative RT was reviewed. LC at RT sites was evaluated with follow-up computed tomography (CT). The influence of treatment-, cancer- and patient-related risk factors for LC was assessed. A total of 317 metastatic lesions in 210 patients with lung cancer were evaluated. The median RT dose (biologically effective dose calculated using an alpha/beta of 10 Gy; BED10) was 39.0 Gy (range, 14.4-50.7 Gy). The median follow-up time for survival and median radiographic follow-up time were 8 (range, 1-127) and 4 (range, 1-124) months, respectively. The 0.5-year overall survival and LC rates were 58.9 and 87.7%, respectively. The local recurrence rate in RT sites was 11.0%, and bone metastatic progression, except in RT sites, was observed in 46.1% at the time of local recurrence or the last follow-up CT of the RT sites. According to multivariate analysis, RT sites, pre-RT neutrophil to lymphocyte ratio (NLR), post-RT non-administration of molecular-targeting agents (MTs), and non-administration of bone modifying agents (BMAs) were significant unfavorable factors for LC of bone metastasis. Moderate RT dose escalation (BED10 >39 Gy) tended to improve the LC of RT sites. In cases without MTs, moderate dose escalation of RT dose improved the LC of RT sites. In conclusion, treatment (post-RT MTs and BMAs), cancer (RT sites) and patient (pre-RT NLR)-related risk factors had a large impact on improving the LC of RT sites. Moderate RT dose escalation seemed to have a small impact on improving the LC of RT sites.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] A Population-based Model of Local Control and Survival Benefit of Radiotherapy for Lung Cancer
    Shafiq, J.
    Hanna, T. P.
    Vinod, S. K.
    Delaney, G. P.
    Barton, M. B.
    CLINICAL ONCOLOGY, 2016, 28 (10) : 627 - 638
  • [42] Functional status in older patients with lung cancer: an observational cohort study
    Couderc, Anne-Laure
    Tomasini, Pascale
    Greillier, Laurent
    Nouguerede, Emilie
    Rey, Dominique
    Montegut, Coline
    Thomas, Pascal-Alexandre
    Barlesi, Fabrice
    Villani, Patrick
    SUPPORTIVE CARE IN CANCER, 2022, 30 (05) : 3817 - 3827
  • [43] Palliative Vitamin C Application in Patients with Radiotherapy-Resistant Bone Metastases: A Retrospective Study
    Gunes-Bayir, Ayse
    Kiziltan, Huriye Senay
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2015, 67 (06): : 921 - 925
  • [44] Continuous palliative sedation in terminally ill patients with cancer: a retrospective observational cohort study from a Chinese palliative care unit
    Tan, Fang
    Chen, Shan
    Huang, Lan
    Chen, Yang
    Wu, Yan
    BMJ OPEN, 2023, 13 (05):
  • [45] FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer
    Zhao, Fen
    Ding, Gang
    Huang, Wei
    Li, Minghuan
    Fu, Zheng
    Yang, Guoren
    Kong, Li
    Zhang, Yan
    Yu, Jinming
    CLINICAL LUNG CANCER, 2015, 16 (06) : E111 - E119
  • [46] Prognostic factors of patients with advanced lung cancer treated with anlotinib: a retrospective cohort study
    Fan, Bijun
    Tan, Xiaoming
    Lou, Yueyan
    Zheng, Yu
    Zhang, Liyan
    Wu, Xueling
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (10)
  • [47] Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR-mutated non-small-cell lung cancer: a retrospective, multicenter cohort study
    Tanaka, Ichidai
    Hori, Kazumi
    Koyama, Junji
    Gen, Soei
    Morise, Masahiro
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Ishii, Makoto
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [48] Whether Primary Bone-Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?-A Large-Cohort Retrospective Study
    Guo, Wan-Ping
    Jia, Guo-Dong
    Xie, Si-Yi
    Yu, Xuan
    Meng, Xiao-Han
    Tang, Lin-Quan
    Li, Xiao-Yun
    Luo, Dong-Hua
    CANCER MEDICINE, 2024, 13 (21):
  • [49] Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter study
    Bassanelli, Maria
    Ricciuti, Biagio
    Giannarelli, Diana
    Cecere, Fabiana Letizia
    Roberto, Michela
    Giacinti, Silvana
    Barucca, Viola
    Santarelli, Mario
    Ruggeri, Enzo Maria
    Marchetti, Paolo
    Cognetti, Francesco
    Gelibter, Alain
    Cortesi, Enrico
    Chiari, Rita
    Milella, Michele
    Ceribelli, Anna
    TUMORI JOURNAL, 2022, 108 (03): : 250 - 257
  • [50] Surgical Intervention for Patients With Spinal Metastasis From Lung Cancer A Retrospective Study of 87 Cases
    Truong, Van Tri
    Shedid, Daniel
    Al-Shakfa, Fidaa
    Hattou, Lotfi
    Shen, Jesse
    Boubez, Ghassan
    Yuh, Sung-Joo
    Wang, Zhi
    CLINICAL SPINE SURGERY, 2021, 34 (03): : E133 - E140